Some families have come to prefer stand-alone virtual schools and districts are rushing to accommodate them — though questions about remote learning persist.
Blog
-
N.R.A. Chief Takes the Stand, With Cracks in His Armor
The New York Times – Business:
Wayne LaPierre has led the National Rifle Association for 30 years, but his implacable image looked threadbare in bankruptcy court.
-
2 Korean Battery Makers Settle Dispute That Threatened Biden’s Green Agenda
The New York Times – Business:
The settlement between LG Energy Solution and SK Innovation ensures that a battery plant in Georgia will go forward without hampering electric vehicle production.
-
The Week in Business: Amazon Defeats the Union
The New York Times – Business:
Amazon workers in Alabama voted down the biggest push for unionizing in the company’s history.
-
My Family’s Global Vaccine Journey
The New York Times – Business:
We were spread across three continents, at the mercy of vaccine geopolitics. Which of us would be inoculated last?
-
The Traveling Work Diary of a Master Distiller
The New York Times – Business:
Marianne Eaves has traded the distillery life for travels with her partner’s circus, connecting to clients in the spirits business from all over the globe.
-
Social Media Etiquette Review
The New York Times – Business:
Despite your best efforts, you may cause someone pain with that Tweet or Facebook post. Here’s a refresher on social media best practices, along with advice for some pandemic-only dilemmas.
-
The Wall Street Journal’s Internal Audit
The New York Times – Business:
A look at what the newsroom’s internal study — The Content Review — concluded about the paper’s faults.
-
Saudi Aramco Sells Oil Pipeline Stake for $12.4 Billion
The New York Times – Business:
Aramco is under pressure from its main owner, the Saudi government, to generate cash to finance state operations as well as new investments.
-
AstraZeneca Vaccine and Blood Clots: What Is Known So Far
The New York Times – Business:
In rare cases, an immune reaction has led to antibodies that caused a serious clotting disorder. But public health experts maintain the vaccine’s benefits far outweigh the risks for most people.